Development of an Antimicrobial Pedicle Screw System:Studies Designed to Mitigate the Risk of Bacterial Resistance

PROJECT SUMMARY/ABSTRACT Chronic pain at the implant site, “failed back surgery syndrome (FBSS),” is a common cause of spine fusion failure. Over the past five years, though, multiple studies have defined a clear link between FBSS and low levels of bacterial contamination on implant surfaces. In particular, these studies showed bacterial contamination in 40% of cases of hardware retrieved from FBSS patients who have otherwise no clinical signs of surgical site infection. In response to this clinical need, Orthobond has developed an antimicrobial pedicle screw implant system utilizing a high density of covalently bound quaternary ammonium compounds (QACs). This pedicle screw system has already demonstrated broad-spectrum antimicrobial efficacy and good biocompatibility; however, in order to commercialize the product, it is necessary to demonstrate that the antimicrobial implants will not promote the emergence of antibiotic-resistant bacteria. QACs are well-known for nearly a century in consumer products such as mouthwashes, shampoos and surface disinfectant sprays; they suffer few reports of bacterial resistance. However, when resistance to QACs does occur, it is through expression of one or more types of efflux pumps that work to remove QACs before they disrupt intracellular targets. We believe that surface-tethered QACs should not be subject to decreased efficacy by efflux pumps; these surface-bound molecules are expected to not enter the bacterium, but rather to act on its cell wall through positive-charge promoted mechanisms. The global aim of this proposed research also includes to implement rapid assays to determine the propensity for our QAC-treated pedicle screw implants to allow emergence of bacterial resistance to them and to other contact-based antimicrobials. This Phase 1 proposal consists of two specific aims, in brief: • Aim 1 is to test whether repeated exposure of Orthobond antimicrobial pedicle screw surfaces togram positive or gram negative bacteria results in decreased susceptibility of these bacteria to theimplants or cross-resistance to commonly used antibiotics. • Aim 2 is to test if surface-bonding the QAC to the pedicle screw system obviates the resistancemechanism to dissolved QACs - expression of the QacA efflux pump gene. The design and implementation of these tests will allow for evaluation of the propensity of the Orthobond antimicrobial pedicle screw system to promote bacterial resistance. These studies will potentially provide critical data needed to market the antimicrobial pedicle screw system to physicians and their patients.